Literature DB >> 1684428

BglII and EcoRI polymorphism of the human nm23-H1 gene (NME1).

J Yagüe1, M Juan, A Leone, M Romero, A Cardesa, J Vives, P S Steeg, E Campo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684428      PMCID: PMC329270          DOI: 10.1093/nar/19.23.6663

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  1 in total

1.  Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development.

Authors:  A M Rosengard; H C Krutzsch; A Shearn; J R Biggs; E Barker; I M Margulies; C R King; L A Liotta; P S Steeg
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

  1 in total
  5 in total

1.  Nm23-H1: genetic alterations and expression patterns in tumor metastasis.

Authors:  M T Hartsough; P S Steeg
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

2.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 3.  Nm23/nucleoside diphosphate kinase in human cancers.

Authors:  M T Hartsough; P S Steeg
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

4.  Associations of non-metastatic cells 1 gene polymorphisms with lymph node metastasis risk of gastric cancer in Northern Chinese population.

Authors:  Ai-Lin Li; Xin Zhou; Zhen-Ning Wang; Yong-Xi Song; Peng Gao; Yuan Miao; Jin-Liang Zhu; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2012-08-19

5.  Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region.

Authors:  B Leggett; J Young; R Buttenshaw; L Thomas; B Young; G Chenevix-Trench; J Searle; M Ward
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.